ImmunoGen, Inc. Announces Conference Call to Discuss its First Quarter Fiscal Year 2014 Financial Results

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, October 25, 2013, to discuss ImmunoGen's financial results for the three-month period ended September 30, 2013. Management also will provide an update on the Company.

Help employers find you! Check out all the jobs and post your resume.